221 related articles for article (PubMed ID: 26519419)
1. A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation.
Drago F; Cogorno L; Broccolo F; Ciccarese G; Parodi A
Osteoporos Int; 2016 Mar; 27(3):1261-1264. PubMed ID: 26519419
[TBL] [Abstract][Full Text] [Related]
2. DRESS syndrome with autoimmune hepatitis from strontium ranelate.
di Meo N; Gubertini N; Crocè L; Tiribelli C; Trevisan G
Cutis; 2016 May; 97(5):E22-6. PubMed ID: 27274555
[TBL] [Abstract][Full Text] [Related]
3. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7).
Draz N; Datta S; Webster DP; Cropley I
BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23904426
[TBL] [Abstract][Full Text] [Related]
4. Human herpesvirus 6 lymphadenitis in drug rash with eosinophilia and systemic symptoms syndrome: a lymphoma mimic.
Johnson S; Mathews S; Hudnall SD
Histopathology; 2017 Jun; 70(7):1166-1170. PubMed ID: 28008656
[TBL] [Abstract][Full Text] [Related]
5. Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate.
Cacoub P; Descamps V; Meyer O; Speirs C; Belissa-Mathiot P; Musette P
Osteoporos Int; 2013 May; 24(5):1751-7. PubMed ID: 23361875
[TBL] [Abstract][Full Text] [Related]
6. Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Tohyama M; Hashimoto K; Oda F; Namba C; Sayama K
J Dermatol; 2020 May; 47(5):476-482. PubMed ID: 32162382
[TBL] [Abstract][Full Text] [Related]
7. DRESS syndrome.
Descamps V; Ranger-Rogez S
Joint Bone Spine; 2014 Jan; 81(1):15-21. PubMed ID: 23816504
[TBL] [Abstract][Full Text] [Related]
8. [Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation].
Funck-Brentano E; Duong T; Family D; Bouaziz JD; Ortonne N; Bagot M; Roujeau JC; Wolkenstein P; Valeyrie-Allanore L
Ann Dermatol Venereol; 2011; 138(8-9):580-5. PubMed ID: 21893231
[TBL] [Abstract][Full Text] [Related]
9. Case report of drug rash with eosinophilia and systemic symptoms demonstrating human herpesvirus-6 reactivation.
Ferrero NA; Pearson KC; Zedek DC; Morrell DS
Pediatr Dermatol; 2013; 30(5):608-13. PubMed ID: 24016284
[TBL] [Abstract][Full Text] [Related]
10. Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS).
Descamps V; Avenel-Audran M; Valeyrie-Allanore L; Bensaid B; Barbaud A; Al Jawhari M; Ranger-Rogez S;
JAMA Dermatol; 2013 May; 149(5):565-9. PubMed ID: 23426332
[TBL] [Abstract][Full Text] [Related]
11. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
13. Immunopathogenic Insights on Preferential Human Herpesvirus-6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms: A Scoping Review.
Zhu H; Ren V
J Cutan Med Surg; 2023; 27(4):388-398. PubMed ID: 37231539
[TBL] [Abstract][Full Text] [Related]
14. Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study.
Chen YC; Chiang HH; Cho YT; Chang CY; Chen KL; Yang CW; Lee YH; Chu CY
Allergy; 2015 May; 70(5):568-75. PubMed ID: 25727950
[TBL] [Abstract][Full Text] [Related]
15. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
Hama N; Abe R; Gibson A; Phillips EJ
J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
[TBL] [Abstract][Full Text] [Related]
16. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Cardones AR
Clin Dermatol; 2020; 38(6):702-711. PubMed ID: 33341203
[TBL] [Abstract][Full Text] [Related]
17. [Strontium ranelate-induced DRESS syndrome].
Le Merlouette M; Adamski H; Dinulescu M; Le Gall F; Colin F; Grimaud H; Chevrant-Breton J
Ann Dermatol Venereol; 2011 Feb; 138(2):124-8. PubMed ID: 21333824
[TBL] [Abstract][Full Text] [Related]
18. The interferon-γ-induced protein 10/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms.
Yang CW; Cho YT; Hsieh YC; Hsu SH; Chen KL; Chu CY
Br J Dermatol; 2020 Nov; 183(5):909-919. PubMed ID: 32037509
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study on the association of human herpesvirus reactivation with severe DRESS: A description of blood and skin reactivations.
Marcombes C; Ingen-Housz-Oro S; Dezoteux F; Staumont-Sallé D; Milpied B; Tetart F; de Prost N; Fourati S; Ortonne N; Kasimir F; Prusty BK; Descamps V
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2550-2557. PubMed ID: 37591509
[TBL] [Abstract][Full Text] [Related]
20. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
